Article
Influence of a genomic classifier on post-operative treatment decisions in high-risk prostate cancer patients: results from the PRO-ACT study.
Current medical research and opinion - 1 Aug 2014
Michalopoulos Steven N, Kella Naveen, Payne Ryan, Yohannes Paulos, Singh Amar, Hettinger Christian, Yousefi Kasra, Hornberger John
Abstract excerpt
OBJECTIVE: To assess the effect of an individualized genomic classifier (GC) test, for predicting metastasis following radical prostatectomy (RP), on urologists' adjuvant treatment decisions when caring for high-risk patients. PATIENTS AND METHODS: Data were submitted by US board-certified urologists in community practices (n = 15), who ordered the GC test for 146 prostate cancer patients with adverse pathologic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
